SCHEMBL22180299

SCHEMBL22180299

COCCN(C)C(=O)Nc1ncc(-c2ccc3ncnc(C)c3c2)c(-c2ccc(F)cc2)n1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 5/20 0.40
▸ ATM Q13315 6/20 0.39
▸ GRM2 Q14416 1/20 0.38
▸ CYP3A4 P08684 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ MTOR P42345 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ DHODH Q02127 2/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ ADORA1 P30542 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30738301 1.00 MAP4K4 (0.40) MAP4K4ATMGRM2CYP3A4ALDH1A1
SCHEMBL22179955 0.85 MAPK1 (0.50) MAP4K4ATMCYP3A4ALDH1A1TSHR
SCHEMBL22179704 0.83 ADORA1 (0.39) GRM2CYP3A4ALDH1A1HSD17B10DHODH
SCHEMBL22179956 0.82 NPC1 (0.42) CYP3A4DHODHADORA1USP2LMNA
SCHEMBL30738378 0.82 NPC1 (0.42) CYP3A4DHODHADORA1USP2LMNA
SCHEMBL29947049 0.82 MAP4K4 (0.46) MAP4K4CYP3A4ALDH1A1TSHRHSD17B10
SCHEMBL21621285 0.82 MAP4K4 (0.46) MAP4K4CYP3A4ALDH1A1TSHRHSD17B10
SCHEMBL21621299 0.82 ADORA1 (0.46) MAP4K4CYP3A4ADORA1USP2LMNA
SCHEMBL22179960 0.81 ABL1 (0.42) MAP4K4CYP3A4TSHRMTORDHODH
SCHEMBL30738303 0.81 ABL1 (0.42) MAP4K4CYP3A4TSHRMTORDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166119-B Substituted aryl compound and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-01-05 — — CN disclosed
US-20210395226-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2021-12-23 — — US disclosed
CN-113166119-A Substituted aryl compound and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2021-07-23 — — CN disclosed
WO-2020135210-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2020-07-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395226-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF ADORA2A, ADORA1, ADORA3 MAP4K4 4157/4885ATM 4192/4885GRM2 3209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback